[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy]

Autor: Alberto, Menozzi, Gianluca Calogero, Campo, Vincenzo, Guiducci, Gianni, Dall'Ara, Andrea, Santarelli, Paolo, Sbarzaglia, Marco, Balducelli, Paolo, Magnavacchi, Fabio, Sgura, Luciano, Losi, Luigi, Vignali, Gianni, Casella, Luigi, Steffanon, Fabio, Tarantino, Francesco, Saia
Přispěvatelé: Menozzi, Alberto, Campo, Gianluca Calogero, Guiducci, Vincenzo, Dall'Ara, Gianni, Santarelli, Andrea, Sbarzaglia, Paolo, Balducelli, Marco, Magnavacchi, Paolo, Sgura, Fabio, Losi, Luciano, Vignali, Luigi, Casella, Gianni, Steffanon, Luigi, Tarantino, Fabio, Saia, Francesco
Jazyk: italština
Rok vydání: 2017
Předmět:
Popis: The bioresorbable vascular scaffold (BRS) technology constitutes the new revolution of the coronary artery disease interventional treatment. Currently, three distinct types of BRSs are available but only one, the Absorb BVS, was on the market in 2013 when the Regional Commission for Medical Devices and the Cardiology and Cardiac Surgery Commission of the Emilia-Romagna Region drew up a technical and scientific essay to provide guidance for the introduction of BRS in public and affiliated health facilities. Five preferential indications were given for use: long coronary lesions (28 mm), ostial lesions (left main stem excluded), complete revascularization in patients aged50 years, diffuse disease (40 mm) or involving the mid/distal left anterior descending (LAD) branch in patients70 years, spontaneous coronary artery dissection.This survey analyzed data from all the catheterization laboratories in the Emilia-Romagna Region, merged in a unified database.In a 3-year study period, 546 BRS were implanted in 328 patients, corresponding to 1.5% of the drug-eluting stents (DES) used, with a trend towards a progressive increase over time. Initial indications were followed in 200/328 (61.0%) patients (about one third fitting more indications), mainly for treatment of long lesions in vessels2.5 mm (67%), young patients (31.5%) and mid/distal LAD (28%). In 22.6% of cases the clinical scenario was a ST-segment elevation myocardial infarction, in 39.3% a non-ST-segment elevation acute coronary syndrome. Intracoronary imaging was infrequently used (intravascular ultrasound in 24.7% of cases). In 85 patients (25.9%) a hybrid procedure (BVS/DES) was performed.BRS use has resulted lower than expected, with discrete variability among centers, but according to the initial indications of the Emilia-Romagna Region in the majority of cases. The underuse might have been due to operators' caution in their initial experience. However, the increasing trend may reveal a greater confidence in the implantation technique and the whole amount of safety and efficacy data.
Databáze: OpenAIRE